Pathogenesis of autoimmune valvular carditis

自身免疫性瓣膜性心脏病的发病机制

基本信息

  • 批准号:
    9815721
  • 负责人:
  • 金额:
    $ 37.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-15 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract Patients with chronic inflammatory/rheumatic diseases suffer increased cardiovascular morbidity and mortality. Improving outcomes requires understanding how chronic inflammation causes cardiovascular pathology. The focus of this proposal is on valvular carditis. The most common cause of valvular carditis is rheumatic heart disease (RHD), which affects >30 million people worldwide and causes >300,000 deaths annually. Valvular carditis also occurs in patients with lupus and the related antiphospholipid antibody syndrome. Our group has pioneered a mouse model of co-existing valvular carditis and inflammatory arthritis, with pathologic features recapitulating those in human patients. Our group was the first to show a critical role for myeloid cells in promoting valvular carditis. Specifically, we showed that autoantibodies engage particular Fc receptors on macrophages, leading to pro-inflammatory cytokine production and macrophage polarization, leading to chronic valve inflammation and fibrosis. We have identified the cytokine interleukin-13 (IL-13) as a key driver of this process. The current proposal builds on these findings and extends them. Here we will identify the cell type producing IL-13; preliminary data suggest type 2 innate lymphoid cells (ILC2s). We will also identify the pathways that lead to increased IL-13 production, focused on cytokines made by endothelial cells. Type 2 immune responses are known to promote tissue fibrosis, which occurs in the cardiac valves of patients with RHD and in our mouse model, characterized by the presence of myofibroblasts in the valves. The cell from which these myofibroblasts originate is not known. We propose sophisticated cell lineage tracing experiments to identify myofibroblast progenitors among valve interstitial cells (VICs) in valvular carditis. Understanding the origin of the myofibroblasts is critical to targeting them therapeutically. Finally, we are focused on the puzzling question of why valvular carditis preferentially affects the left-sided heart valves (mitral and aortic) and not the right-sided ones – this is true in both human patients and the mouse model. Many possibilities exist. Our preliminary data show that the expression of key genes and proteins involved in type 2 immunity or in sensing biophysical variables (e.g. oxygen tension and shear stress) differs between the left- and right-sided valves in normal mice. We therefore propose to perform comprehensive analysis of cardiac valve gene expression to identify molecular pathways that underlie this left-sided predilection. Guided by these data, we will interrogate the most promising of these pathways. In sum, we will define how discrete populations of immune cells interact with endothelial cells and VICs to cause chronic valve inflammation and fibrosis. Further, we will reveal why the milieu of the left side of the heart promotes inflammation and fibrosis. Although we are focused here on valvular carditis, we expect that our findings will be generalizable to other types of cardiovascular inflammation, including atherosclerosis.
摘要 慢性炎症/风湿性疾病患者心血管发病率和死亡率增加。 改善结果需要了解慢性炎症如何导致心血管病理学。的 该建议的重点是瓣膜性心脏炎。瓣膜性心脏炎最常见的原因是风湿性心脏病 风湿性心脏病(RHD),其影响全世界超过3000万人,并且每年导致超过300,000人死亡。瓣膜 心脏炎也发生在狼疮和相关的抗磷脂抗体综合征患者中。我们集团 开创了一种同时存在瓣膜性心脏炎和炎性关节炎的小鼠模型, 在人类患者中重现。我们的研究小组是第一个显示骨髓细胞在 导致心脏瓣膜炎具体来说,我们发现自身抗体与特定的Fc受体结合, 巨噬细胞,导致促炎细胞因子产生和巨噬细胞极化,导致 慢性瓣膜炎症和纤维化。我们已经确定了细胞因子白细胞介素-13(IL-13)是 这个过程目前的提案是在这些调查结果的基础上提出的,并加以扩展。在这里,我们将识别细胞类型 产生IL-13;初步数据表明2型先天淋巴样细胞(ILC 2)。我们还将确定 导致IL-13产生增加的途径,重点是内皮细胞产生的细胞因子。2型 已知免疫应答促进组织纤维化,其发生在患有心脏病的患者的心脏瓣膜中。 RHD和我们的小鼠模型,其特征在于瓣膜中存在肌成纤维细胞。细胞免受 这些肌成纤维细胞的来源尚不清楚。我们提出了复杂的细胞谱系追踪实验 目的:鉴定心瓣膜炎瓣膜间质细胞(VIC)中的心肌成纤维细胞祖细胞。了解 肌成纤维细胞的来源对于治疗上靶向它们是关键的。最后,我们关注的是令人费解的 为什么心脏瓣膜炎优先影响左侧心脏瓣膜(二尖瓣和主动脉瓣)而不是 右侧的-这在人类患者和小鼠模型中都是正确的。存在许多可能性。我们 初步数据显示,参与2型免疫或感觉的关键基因和蛋白质的表达, 生物物理变量(例如氧张力和剪切应力)在左侧和右侧瓣膜之间不同, 正常小鼠因此,我们建议对心脏瓣膜基因表达进行全面分析, 确定这种左侧偏好背后的分子途径。在这些数据的指导下,我们将审问 这些途径中最有希望的。总之,我们将定义免疫细胞的离散群体如何相互作用 与内皮细胞和VIC一起引起慢性瓣膜炎症和纤维化。此外,我们将揭示为什么 心脏左侧的环境促进炎症和纤维化。虽然我们在这里关注的是 对于心瓣膜炎,我们希望我们的发现能推广到其他类型的心血管炎症, 包括动脉粥样硬化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bryce Binstadt其他文献

Bryce Binstadt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bryce Binstadt', 18)}}的其他基金

A novel autoinflammatory skin disease in a patient with mutations in alpha-T-catenin
α-T-连环蛋白突变患者的一种新型自身炎症性皮肤病
  • 批准号:
    10055124
  • 财政年份:
    2020
  • 资助金额:
    $ 37.66万
  • 项目类别:
A novel autoinflammatory skin disease in a patient with mutations in alpha-T-catenin
α-T-连环蛋白突变患者的一种新型自身炎症性皮肤病
  • 批准号:
    10197026
  • 财政年份:
    2020
  • 资助金额:
    $ 37.66万
  • 项目类别:
Pathogenesis of autoimmune valvular carditis
自身免疫性瓣膜性心脏病的发病机制
  • 批准号:
    10624894
  • 财政年份:
    2014
  • 资助金额:
    $ 37.66万
  • 项目类别:
Macrophages as effectors of autoimmune valvular carditis
巨噬细胞作为自身免疫性瓣膜性心脏病的效应器
  • 批准号:
    9086419
  • 财政年份:
    2014
  • 资助金额:
    $ 37.66万
  • 项目类别:
Macrophages as effectors of autoimmune valvular carditis
巨噬细胞作为自身免疫性瓣膜性心脏病的效应器
  • 批准号:
    8754860
  • 财政年份:
    2014
  • 资助金额:
    $ 37.66万
  • 项目类别:
Pathogenesis of autoimmune valvular carditis
自身免疫性瓣膜性心脏病的发病机制
  • 批准号:
    10418653
  • 财政年份:
    2014
  • 资助金额:
    $ 37.66万
  • 项目类别:
Macrophages as effectors of autoimmune valvular carditis
巨噬细胞作为自身免疫性瓣膜性心脏病的效应器
  • 批准号:
    8890874
  • 财政年份:
    2014
  • 资助金额:
    $ 37.66万
  • 项目类别:
Pathogenesis of autoimmune valvular carditis
自身免疫性瓣膜性心脏病的发病机制
  • 批准号:
    9926159
  • 财政年份:
    2014
  • 资助金额:
    $ 37.66万
  • 项目类别:
A mouse to track dual TCR T cells
追踪双 TCR T 细胞的小鼠
  • 批准号:
    8563789
  • 财政年份:
    2013
  • 资助金额:
    $ 37.66万
  • 项目类别:
A mouse to track dual TCR T cells
追踪双 TCR T 细胞的小鼠
  • 批准号:
    8660288
  • 财政年份:
    2013
  • 资助金额:
    $ 37.66万
  • 项目类别:

相似海外基金

Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
  • 批准号:
    23K07659
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
  • 批准号:
    23K15705
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
  • 批准号:
    23K19490
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
  • 批准号:
    10697567
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
  • 批准号:
    10727765
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
  • 批准号:
    23K08467
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
  • 批准号:
    493138
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
  • 批准号:
    23K13905
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
  • 批准号:
    2223225
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
    Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
  • 批准号:
    10651054
  • 财政年份:
    2023
  • 资助金额:
    $ 37.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了